We know exercise is good for you. Why? He‘s working on it.
Gerszten Lab
Investigating Personal Genomics and Cardiometabolic Disease
Discovering Disease Before it Begins
The Gerszten Lab is a national leader in metabolomics and proteomics technologies. Among its key discoveries, the lab has identified novel biomarkers that single out individuals destined to develop diabetes and heart disease more than a decade before disease onset, with the goal of determining which of these patients might benefit from early clinical interventions.
Our Research
Latest News
Novel Biomarker and Pathway Discovery
The Gerszten Lab is taking a close look at molecular signs of disease with the goal of uncovering early risk factors and identifying high-risk individuals appropriate for preventive interventions.